Browse > Article

The Effects of HyungBangSaBaek-San(JingFangXieBaiSan) on the Alzheimer's Disease Model Induced by βA  

Yoon, Jong-Cheon (Dept. of Oriental Neuropsychiatry, College of Oriental Medicine, Dae-Jeon University)
Lee, Sang-Ryong (Dept. of Oriental Neuropsychiatry, College of Oriental Medicine, Dae-Jeon University)
Jung, In-Chul (Dept. of Oriental Neuropsychiatry, College of Oriental Medicine, Dae-Jeon University)
Publication Information
Journal of Oriental Neuropsychiatry / v.21, no.2, 2010 , pp. 171-189 More about this Journal
Abstract
Objectives : This research investigates the effect of the HBSBS on Alzheimer's disease. Specifically, the effects of the HBSBS extract on (1) the behavior (2) the infarction area of the hippocampus, and brain tissue injury in Alzheimer's disease mice induced with $\beta$A were investigated. Methods : The effects of the HBSBS extract suppressed the expression of IL-1$\beta$, IL-6, TNF-$\alpha$ and NOS-II mRNA in BV2 microglial cell line treated with LPS plus $\beta$A were investigated. The effects of the HBSBS extract on the behavior of the memory deficit mice induced by scopolamine were investigated. Results : 1. The HBSBS extract suppressed the expression of IL-1$\beta$, IL-6, TNF-$\alpha$ and NOS-II mRNA in BV2 microglial cell line treated with LPS plus $\beta$A. 2. The HBSBS extract suppressed the expression of $\beta$A protein production in BV2 microglial cell line treated with LPS plus $\beta$A. 3. The HBSBS extract showed significantly inhibitory effect on the scopolamine-induced impairment of memory in the experiment of Morris water maze. 4. The HBSBS group suppressed the over-expression of IL-1$\beta$ protein, TNF-$\alpha$ protein significantly in the mice with Alzheimer's disease induced by $\beta$A. 5. The HBSBS group reduced the infarction area of hippocampus, and controlled the injury of brain tissue in the mice with Alzheimer's disease induced by $\beta$A. 6. The HBSBS group reduced tau protein, and GFAP in the brain tissue of the mice with AD induced by $\beta$A. Conclusions : These results suggest that the HBSBS group may be effective for the treatment of AD. Thus, HBSBS could be considered among the future therapeutic drugs indicated for the treatment of AD.
Keywords
Alzheimer's disease; Hyungbangsabaek-san(JingFangXieBaiSan); Memory deficit; Proinflammatory cytokines;
Citations & Related Records
Times Cited By KSCI : 12  (Citation Analysis)
연도 인용수 순위
1 Binetti G, Mega MS, Magni E, Padovani A, Rozzini L, Bianchetti A. Behavioral disorders in Alzheimer disease: a transcultural perspective. Arch Neurol. 1998;55:539-44.   DOI   ScienceOn
2 Blasi E, Barluzzi R, Bocchini V, Mazzolla R, Bistoni F. Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus. J Neuroimmunol. 1990;27:229-37.   DOI   ScienceOn
3 Bouras C, Hof PR, Giannakopoulos P, Michel JP, Morrison JH. Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: a quantitative evaluation of a one-year autopsy population from a geriatric hospital. Cereb Cortex. 1994;4(2):138-50.   DOI   ScienceOn
4 Joo SS, Won TJ, Lee DI. Potential role of ursodeoxycholic acid in suppression of nuclear factor kappa B in microglial cell line (BV-2). Arch Pharm Res. 2004;27:954-60.   과학기술학회마을   DOI   ScienceOn
5 Lemere CA, Lopera F, Kosik KS, Lendon CL, Ossa J, Saido TC, Yamaguchi H, Ruiz A, Maritnez A, Madrigal L, Hincapie L, Arango JC, Anthony DC, Koo EH, Goate AM, Selkoe DJ, Arango JC. The E280A presenilin 1 Alzheimer mutation produces increased $A{\beta}$ 42 deposition and severe cerebellar pathology. Nat Med. 1996;2(10): 1146-50.   DOI   ScienceOn
6 박지운. 日黃連이 치매병태모델에 미치는 영향. 동의신경정신과학회지. 2004;15(1):87-100.   과학기술학회마을
7 錢鏡湖. 辨證奇問全書. 台北:甘地出版社. 1990: 222-35.
8 洪元植. 精校黃帝內經素問. 서울:東洋醫學硏究 院. 1985:37, 124, 196, 217-8, 229.
9 대한한방신경정신과학회편. 한방신경정신의학. 서울:집문당. 2005:311-6.
10 서유헌. 뇌의학연구의 최근 동향과 전망. 보건산업기술동향. 2002;봄:3-9.
11 Heinz A. Alzheimer disease: a status report for 2002. American Council on Science and Health. 2002.
12 Neal R. Review of the next generation of Alzheimer's disease therapeutics: Challenges for drug development. Prog Neuro-Psychopharmacol & Bio Psychiat. 2001;25: 27-57.   DOI   ScienceOn
13 Chen G, Chen KS, Knox J, Inglis J, Bernard A, Martin SJ. A learning deficit related to age and ${\beta}$-amyloid plaques in a mouse model of Alzheimers disease. Nature. 2000; 408:975-9.   DOI   ScienceOn
14 Suzuki N, Cheung T, Cai X, Odaka A, Otvos L, Eckman C, Golde T, Younkin S. Science. 2004:264, 1336-40.
15 申佶求. 신씨본초학. 서울:壽文社. 1988:89, 218, 283, 286, 357, 369, 615, 629, 1988.
16 Brain R, Douglas H, Hishyuki M, Grant S, Kathryn E. Ramesh R, Raymond T, Tracy K. Metabolic quantification of lesion volume following experimental traumatic brain injury in the rat. Journal of Neurotrauma. January. 1997;14:15-22.   DOI   ScienceOn
17 Vosselera M, Abegunewardenea N, Hoffmannb N, Petersene SE, Beckera D, Cleppienb D, Kunzc P, Kreitnerc KF, Lauterbacha M, Bierbachd B, Düberc C, Goria T, Münzela T, Schreiberb LM, Horsticka G. Area at risk and viability after myocardial ischemia and reperfusion can be determined by contrast -enhanced cardiac magnetic resonance imaging. Eur Surg Res. 2009;43:13-23.   DOI   ScienceOn
18 Tariot MD, PN et al for the memantine study group. Memantine treatment in patients with moderate to severe alzheimer disease already receiving donepezil; A randomized controlled trial. Journal of the American Medical Association. 2004;291:317-24.   DOI   ScienceOn
19 Suematsu T, Matsumura T, Sato N. Lipid peroxidation in alcoholic liver disease in humans. Alcohol Clin Exp Res. 1981;5:427-30.   DOI   ScienceOn
20 Gertsch J, Güttinger M, Sticher O, Heilmann J. Relative quantification of mRNA levels in Jurkat T cells with RT-real time-PCR (RT-rt -PCR): new possibilities for the screening of anti-inflammatory and cytotoxic compounds. Pharm Res. 2002;19:1236-43.   DOI   ScienceOn
21 김지현. 새로운 제형의 치매치료제제의 효능 연구. 동의생리병리학회지. 2002;16(2):303-10.   과학기술학회마을
22 Bradford, M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein -dye binding" anal. Biochem. 1976;72:248-54.
23 Louise B, Asha N, Barbara C, Greer M. $\beta$-Amyloid peptide secretion by a microglial cell line is induced by ${\beta}$-Amyloid (25-35) and lipopolysaccharide. The journal of biological chemistry. 1996:271, 16084-9.   DOI   ScienceOn
24 Bocchini V, Mazzolla R, Barluzzi R, Blasi E, Sick P, Kettenmann H. An immortalized cell line expresses properties of activated microglial cells. J Neurosci Res. 1992;31:616 -21.   DOI   ScienceOn
25 김경석. 갱년기 장애 환자를 少陽人 형방사 백산으로 치료한 치험 1례. 사상체질의학회지. 2003;15(3):118-23.   과학기술학회마을
26 이기주. 十二味貫中湯 凉膈散火湯, 荊防瀉白 散이 백서의 혈압 및 국소뇌혈류량에 미치는 영향. 한국전통의학지. 1999:263-72.
27 이승희. 귀비총명탕 열수추출물과 초미세분 말제형이 Alzheimer's Disease 병태 모델에 미치는 영향. 동의생리병리학회지. 2007;21(4): 921-33.   과학기술학회마을
28 강형원. 김상태, 손형진, 한평림, 조형권, 이영재, 유영수. LMK02의 품질규격화와 $A{\beta}$ 올리고머에 의해 유도된 흰쥐해마 H19-7세 포주에 미치는 항치매효과. 동의생리병리학회지. 2009;23(2):397-404.   과학기술학회마을
29 이제마. 東醫壽世保元. 서울:행림출판. 1986:102.
30 이상민. 배영춘. 유관석. 주종천. 서은희. 소양인 임신오저환자를 형방사백산으로 치료 한 치험례. 사상체질의학회지. 2004;16(2):114- 21.
31 오영진. 총명탕과 향부자총명탕의 추출물, 나노분말 제형을 이용한 치매에 관한 연구. 동의신경정신과학회지. 2006;17(1):79-105.   과학기술학회마을
32 한원주. 김형수. 김상태. 김태헌. 류영수. 강형원. 원지와 석창포의 단독 및 혼합추출액 이 CT105 로 유도된 신경세포암 세포주에 미치는 영향. 동의신경정신과학회지. 2003;14(2): 95-105.   과학기술학회마을
33 張介賓. 張氏景岳全書. 서울:翰成社. 1978:610-1.
34 박인상. 동의사상요결. 서울:소나무. 1991:63-4, 248.
35 김명진. 木瓜가 CT-105로 유도된 Alzheimer's Disease 병태 모델에 미치는 영향. 동의신경정신과학회지. 2005;16(1):97-118.   과학기술학회마을
36 박경. 補中益氣湯加味方 투여로 호전된 혈관성 치매 환자 1례 보고. 동의생리병리학회지. 2008; 22(4):943-7.   과학기술학회마을
37 Fuh JL, Wang SJ, Cummings JL. Neuropsychiatric profiles in patients with Alzheimer's disease and vascular dementia. J Neurol Neurosurg Psychiatry. 2005;76:1337-41.   DOI   ScienceOn
38 Cummings JL. Frontal-subcortical circuits and human behavior. Arch Neurol. 1993;50:873-80.   DOI   ScienceOn
39 원호영. 반하백출천마탕이 국소 뇌허혈로 인한 치매 병태 백서에 미치는 영향. 대한한방신격정신과학회. 2006;17(2):61-73.   과학기술학회마을
40 임정화. 총명탕과 파극천총명탕 열수추출물, 초미세분말제형이 microglia 및 기억력 감퇴 병태모델에 미치는 영향. 동의생리병리학회지. 2006;20(4):997-1008.   과학기술학회마을